SynCoreBio signed co-develop contract of SB04 with A...
2015-06-03
SynCorebio (4192) announced that the company signed co-develop contract with AJU PHARM Korea. AJU PHARM will be in a part of th... more

SB01-An investigational New drug for Head and Neck C...
2015-05-29
 A New Milestone in Research and Development ! The research and development of SB01 has made significant breakthroughs... more

Collaboration Between SynCore Biotechnology Co., Ltd...
2015-01-31
Age-related macular degeneration is a common retinal disease characterized by degenerative visual acuity and eventual vision lo... more

SynCore Biotechnology Co., Ltd. held the Investor Co...
2014-11-07
SynCore Biotechnology Co., Ltd. held the Investor Conference at Shangri-La’s Far Eastern Plaza Hotel on 2nd October befor... more

The common stock of SyncoreBio Corp. (stock code: 41...
2014-11-07
SynCore Biotechnology (stock code: 4192) was public listed on October 28, 2014. The SynCore team led by the company’s Cha... more